The historical rank and industry rank for Shattuck Labs's Days Sales Outstanding or its related term are showing as below:
STTK's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 72.4 * Ranked among companies with meaningful Days Sales Outstanding only.
Shattuck Labs's Days Sales Outstanding
stayed the same
from Dec. 2023 (0.00) to Dec. 2024 (0.00).
Shattuck Labs Days Sales Outstanding Historical Data
The historical data trend for Shattuck Labs's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Shattuck Labs's Days Sales Outstanding
For the Biotechnology subindustry, Shattuck Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shattuck Labs's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shattuck Labs's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Shattuck Labs's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shattuck Labs (NAS:STTK) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Shattuck Labs Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Shattuck Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STTK has been successfully added to your 